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ABSTRACT
Introduction: There is increasing evidence that
electronic prescribing (ePrescribing) or computerised
provider/physician order entry (CPOE) systems can
improve the quality and safety of healthcare services.
However, it has also become clear that their
implementation is not straightforward and may create
unintended or undesired consequences once in use. In
this context, qualitative approaches have been
particularly useful and their interpretative synthesis
could make an important and timely contribution to the
field. This review will aim to identify, appraise and
synthesise qualitative studies on ePrescribing/CPOE
in hospital settings, with or without clinical
decision support.
Methods and analysis: Data sources will include the
following bibliographic databases: MEDLINE, MEDLINE
In Process, EMBASE, PsycINFO, Social Policy and
Practice via Ovid, CINAHL via EBSCO, The Cochrane
Library (CDSR, DARE and CENTRAL databases),
Nursing and Allied Health Sources, Applied Social
Sciences Index and Abstracts via ProQuest and
SCOPUS. In addition, other sources will be searched
for ongoing studies (ClinicalTrials.gov) and grey
literature: Healthcare Management Information
Consortium, Conference Proceedings Citation Index
(Web of Science) and Sociological abstracts. Studies
will be independently screened for eligibility by 2
reviewers. Qualitative studies, either standalone or in
the context of mixed-methods designs, reporting the
perspectives of any actors involved in the
implementation, management and use of ePrescribing/
CPOE systems in hospital-based care settings will be
included. Data extraction will be conducted by 2
reviewers using a piloted form. Quality appraisal will be
based on criteria from the Critical Appraisal Skills
Programme checklist and Standards for Reporting
Qualitative Research. Studies will not be excluded
based on quality assessment. A postsynthesis
sensitivity analysis will be undertaken. Data analysis
will follow the thematic synthesis method.
Ethics and dissemination: The study does not
require ethical approval as primary data will not be
collected. The results of the study will be published in
a peer-reviewed journal and presented at relevant
conferences.
Trial registration number: CRD42016035552.
INTRODUCTION
In recent years, an increasing body of evi-
dence supports that electronic prescribing
(ePrescribing) or computerised provider/
physician order entry (CPOE) systems can
improve medication safety and quality of
healthcare services by reducing risks of medi-
cation errors1 2 and improving organisational
efﬁciency and health professionals’ perform-
ance throughout the medication process.2 3
However, alongside the potential beneﬁts
of ePrescribing applications for patients,
Strengths and limitations of this study
▪ Although a number of systematic reviews have
been conducted to date on electronic prescribing
(ePrescribing) or computerised provider/phys-
ician order entry systems, only a few have
focused on hospital settings.
▪ According to the scoping searches conducted by
the authors, only two existing reviews included
qualitative studies, of which only one focused on
providers’ perceptions in a hospital setting.
▪ To the best of the knowledge of the authors, this is
the first systematic review of qualitative evidence
relating to the management and use/optimisation
of ePrescribing systems in hospital settings, not
limited to the implementation process, and includ-
ing any reported perspectives (ie, not only health
professionals and also managers, commissioners,
patients and relatives/carers).
▪ The review will not address perceptions and
experiences related to non-hospital-based
settings.
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professionals and healthcare systems/organisations, it
has also become clear that their implementation is not
straightforward and may create unintended or undesired
consequences once in use,3–6 with potentially adverse
effects on clinical workﬂows7 and collaborative work8
such as increased data entry tasks and redistribution of
work and time for patient care9 or reduced interactions
between nurses and doctors.10 Likewise, as work prac-
tices change, hospital staff have to learn new ways of
working, which can also result in the development of
‘workarounds’ where technology is used in ways other
than intended.11–13 This, together with the inherent dif-
ﬁculty of demonstrating the impact of health informa-
tion technologies (HITs) on clinical outcomes2 14 due to
the systemic nature of changes brought about by HIT
implementation, means that inductive exploratory
approaches of a qualitative nature can make an import-
ant contribution to this ﬁeld.9 15–17
Qualitative approaches are particularly well suited to
(1) understanding how systems are used in practice,
including the identiﬁcation of unintended conse-
quences, to inform the implementation, development
and optimisation of ePrescribing systems in speciﬁc con-
texts;3 18–21 (2) considering the role of social and organ-
isational factors alongside technology in the
implementation process;8 12 22 and (3) making sense of
complex data about quality and safety, which cannot be
straightforwardly classiﬁed or quantiﬁed and therefore
cannot be elicited from sources such as audit data,
routine metrics and statistics or incident-reporting
systems.23–26
On this basis, the proposed systematic review will
collate, assess and analyse the current evidence relating
to perceptions and experiences of those involved in the
implementation, management, use and optimisation of
ePrescribing systems in the hospital setting.
A number of systematic reviews have been conducted
to date on ePrescribing/CPOE systems: ﬁve reviews used
quantitative approaches27–31 and two used qualitative
approaches,32 33 of which only one focused on user per-
ceptions of ePrescribing system implementation in a hos-
pital setting.33 However, this review was restricted to
health professionals’ perceptions of implementation (ie,
barriers and facilitators to the implementation process)
and therefore did not include (1) any experiences relat-
ing to the use of ePrescribing systems beyond the ‘imple-
mentation stage’ and (2) any experiences from other
actors involved in and/or affected by ePrescribing such
as service managers, commissioners, patients and rela-
tives/carers. In addition, there were some methodo-
logical limitations to this review such as the adoption of
an aggregative (rather than interpretative) approach to
data synthesis, language restrictions and exclusion of
poor quality studies. Thus, given the very limited
number of primary studies previously identiﬁed (n=5), a
systematic review of qualitative studies with a broader
focus and an interpretative approach is needed. It is
anticipated that this will move the ﬁeld forward by
deepening our conceptual understandings of the imple-
mentation, management, use and optimisation of
ePrescribing from the perspectives of those involved.
Aims and objectives
The aim of this review is to explore the perceptions and
experiences of the implementation, management, use
and optimisation of ePrescribing/CPOE systems with
or without clinical decision support (CDS) in the
hospital setting.
Objectives
▸ To identify, appraise and synthesise primary qualita-
tive studies on ePrescribing/CPOE systems, with or
without CDS, in hospital settings.
▸ To explore/interpret the contribution of such ﬁnd-
ings to the understanding of the perceptions and
experiences of those involved in the implementation,
management, use and optimisation of ePrescribing/
CPOE systems in hospital settings.
METHODS AND ANALYSIS
Design
This systematic review will follow the reporting guidelines
formulated in the ‘Enhancing transparency in reporting
the synthesis of qualitative research’ (ENTREQ)
statement.34
Search strategy
The following sources will be searched for primary
studies:
▸ Bibliographic databases: MEDLINE, MEDLINE In
Process, EMBASE, PsycINFO, Social Policy and
Practice via Ovid, CINAHL via EBSCO, The
Cochrane Library (CDSR, DARE and CENTRAL data-
bases), Nursing and Allied Health Sources, Applied
Social Sciences Index and Abstracts (ASSIA) via
ProQuest and SCOPUS.
▸ Sciences and Social Sciences Citation Index (Web of
Science) for citation searching.
▸ ClinicalTrials.gov for ongoing studies.
▸ Checking of citation lists of included studies and rele-
vant reviews.
▸ Grey literature sources: Healthcare Management
Information Consortium, Conference proceedings cit-
ation index (Web of Science) and Sociological
abstracts.
▸ Selected specialist journals in the ﬁeld of health
informatics and qualitative research will be hand
searched for additional relevant studies.
A comprehensive search strategy will be conducted
with the use of search ﬁlters35 36 or Medical Subject
Headings terms relating to qualitative and mixed-
methods research where appropriate in order to identify
relevant qualitative studies. A combination of text words
and index terms will be used for each of the two main
sets of concepts relating to the perspective (including
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terms such as perceptions, attitudes, views and experi-
ences) and intervention (including terms such as
ePrescribing, CPOE and CDS) including variations and
permutations of search terms tested and used in previ-
ous systematic reviews with a similar scope.2 33 37–39
There will be no restriction on date or language of pub-
lication. A sample search strategy for MEDLINE is pro-
vided (see online supplementary appendix 1) and this
strategy has been adapted for use in each bibliographic
database.
Selection criteria
The literature search results will be imported into
EndNote X7.4 (Thomson Reuters, New York) in order
to remove duplicate records and complete the study
selection process. Two reviewers will independently
screen articles for eligibility using predetermined inclu-
sion/exclusion criteria (table 1). Any discrepancies
between reviewers will be resolved by discussion or with
the involvement of a third reviewer where consensus was
not reached. Translation of non-English language arti-
cles will be undertaken if necessary. The selection
process will be illustrated using a Preferred Reporting
Items for Systematic Reviews and Meta-Analyses ﬂow
diagram.40
Setting
Any hospital-based care setting will be included. Other
settings such as primary care, non-hospital-based
clinics, non-hospital-based secondary/tertiary care, non-
hospital-based community care and residential care set-
tings will be excluded. In cases where a study includes
non-hospital-based and hospital-based settings, a deci-
sion regarding study inclusion will be made on the basis
of the reported data that belong to the hospital side of
the study being identiﬁable and extractable.
Perspective
This review will not focus on a particular perspective,
and therefore, studies of any types of participants will be
included. Participants/perspectives included in the
review may comprise, but are not limited to, the follow-
ing: service providers (including doctors, nurses, phar-
macists and any allied health professionals who are
Table 1 Inclusion and exclusion criteria for study selection
Include Exclude
Study design
▸ Qualitative studies, standalone
▸ Qualitative studies in the context of mixed-methods or other
designs
▸ Systematic reviews of qualitative studies (at least one
database searched)
▸ Quantitative studies
▸ Clearly commentary/letter only with no new data from
primary studies
▸ Clearly narrative review (no mention of any database
searched)
Publication type
▸ Full article
▸ Letter
▸ Conference abstracts
▸ Study report
▸ Letter with a commentary on other studies only
Setting
▸ Any hospital-based care setting
▸ Include any mixed-care setting at this stage
▸ Primary care settings
▸ Clinics not hospital-based
▸ Secondary/tertiary care not hospital-based
▸ Community care not hospital-based
▸ Residential care setting
Perspective—population
▸ All individuals involved in electronic prescribing systems’
implementation, use and management such as: service
providers (including doctors, nurses, pharmacists and allied
health professionals), service users (including patients and
family members or relatives of patients), personnel involved
in the management and/or implementation, policymakers or
commissioners responsible for the introduction of such
systems
None
Intervention
▸ Any electronic system, or subsystem, involved in the
prescription and/or administration phase of the medication
process
▸ Any electronic system not involved in the prescription
and/or administration phases of the medication process
(eg, robots that pick drugs for dispensing and systems
for stock control are excluded)
Evaluation—outcomes
No restriction by outcome
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involved in the use of ePrescribing systems), service
users (including patients and relatives/carers of
patients), personnel involved in the management and/
or implementation of ePrescribing systems and policy-
makers or commissioners responsible for the introduc-
tion of ePrescribing systems.
Intervention
Any electronic system, or subsystem, involved in the pre-
scription and/or administration of medication will be
included. This comprises studies of CDS systems within
or alongside ePrescribing/CPOE and studies of elec-
tronic health records systems that include ePrescribing/
CPOE. In the latter case, studies will only be included if
the ePrescribing/CPOE-related data are identiﬁable and
extractable. Electronic systems only involved in other
phases of the medication process (documenting/tran-
scribing, dispensing or monitoring) will be excluded.
Comparison
No restrictions applied.
Evaluation
Any qualitative studies focusing on the perceptions and
experiences of those involved in the implementation,
management, use and optimisation of ePrescribing
systems in a hospital setting. The main outcome of this
review will be to identify key issues and areas of import-
ance from the users’ perspectives to inform the quality
and safety of healthcare services delivery.
Quality appraisal
Quality appraisal of included studies will be conducted
using a tool developed speciﬁcally for the review based
on items from the Critical Appraisal Skills Programme
Qualitative Research Checklist,41 and the Standards for
Reporting Qualitative Research.42 The methodological
quality of each study will be appraised by two reviewers
independently and the outcome and reasons for their
assessments recorded. Disagreements will be resolved by
discussion or referral to a third reviewer.
Given the inherent difﬁculty of appraising all aspects
of quality of qualitative research,43 studies will not be
excluded based on quality or adequacy of the reporting.
Instead, a postsynthesis sensitivity analysis44 will be
undertaken to explore whether any particular ﬁnding or
group of ﬁndings is dependent, either exclusively or
disproportionately, on one or more studies classiﬁed as
‘low quality’ or ‘inadequately reported’ by the review
team. The quality appraisal and sensitivity analysis will
enable an accurate judgement of the quality of the evi-
dence included in the review, which will be discussed
and considered in the reporting of the ﬁndings. In add-
ition, it will indicate any issues shared by studies that
should be considered when designing any new qualita-
tive studies.
Data extraction
Data extraction will be conducted by two reviewers using
a standardised piloted data extraction form.
Discrepancies will be resolved through discussion or
referral to a third reviewer. The following (but not
limited to) information will be extracted from all
included studies:
▸ Purpose of the study and speciﬁc objectives or
research questions;
▸ Study characteristics, study location (eg, country,
setting);
▸ Population (eg, number, age, gender, recruitment/
sampling strategies);
▸ Qualitative approach and research paradigm (eg,
grounded theory, ethnography, phenomenology);
▸ Data collection methods;
▸ Data analysis methods;
▸ Results.
We will understand the ﬁndings to be all of the text
labelled as ‘results’ or ‘ﬁndings’ in the selected papers.
Included data will therefore include verbatim data
extracts from participants as well as authors’ descrip-
tions, summaries and interpretation of primary data.
These will also be used to contextualise and facilitate
the interpretation of primary ﬁndings included in the
review.
Data analysis
The results sections of the included studies will be
entered, verbatim, into QSR NVivo 10 software and will
be treated as qualitative data.
We will then undertake a thematic synthesis,45 which
we consider particularly suitable for this work, where
included studies are likely to bring in a wide range of
intervention features (systems’ scope and functional-
ities), settings (including different countries) and per-
spectives that could hinder the potential for conceptual
innovation. A key strength of using thematic analysis is
the ﬂexibility that this method offers in this respect, that
is, it is possible to synthesise with or without conceptual
innovation using thematic synthesis. While the review
team will be aiming for an analytical (rather than
descriptive) synthesis output, if establishing analytical
themes were to be deemed problematic by the review
team, it would still be possible to produce a satisfactory
synthesis using this method. Also, thematic synthesis has
been regarded as a suitable and relevant method for
synthesising qualitative research in the context of health
technology assessment.46
Following Thomas and Harden,45 this will involve
three overlapped and inter-related stages: (1) line-by-line
coding of the ﬁndings of the primary studies, (2) cat-
egorisation of codes into descriptive themes and (3)
development of analytical themes to describe and/or
explain all of the previous descriptive themes. As we will
adopt an inductive approach to data analysis, the main
analytical concern of the review has not been established
beforehand. During the initial descriptive stage of the
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data analysis process, we expect to identify the main
issues reported by primary studies alongside the range
of aspects that frame them, including perspectives/types
of participants, implementation stages, system function-
ality and level of care, that might be deemed relevant
once the reviewers achieve familiarity with the extracted
primary data. These will then be critically discussed and
put in relation to the main emerging descriptive themes
to then consider the focus of the analytical stage of the
thematic synthesis.
To ensure the robustness of the ﬁndings, various veriﬁca-
tion procedures will be undertaken including:
▸ Multiple coding: data will be codiﬁed independently
by two reviewers.
▸ Reviewer triangulation: three reviewers will compare
their interpretations of the two codebooks.
▸ Data sessions: these will be held at various stages and
will involve all members of the review team to (1)
discuss and agree on the coding framework; (2)
establish and reﬁne descriptive themes; (3) discuss
and agree analytical themes and interpretative frame-
work and (4) discuss any emerging issues from the
sensitivity analysis and establish ﬁnal results.
DISCUSSION
Those involved in and/or affected by technologies
aimed at supporting the medication prescription and
administration process in hospital settings will include
not only health professionals and also other actors such
as patients and relatives/carers, managers, commis-
sioners or HIT professionals.
A better understanding of the range of actors and their
perspectives of implementing and using ePrescribing
technologies in hospital settings could help to develop
new measures of impact for future research and quantita-
tive impact evaluations, and offer new insights into the
implementation process of such technologies by bringing
together perspectives from strategic, social, organisa-
tional and technical backgrounds.8 22
Also, this work might open up new angles from which
to consider key ﬁndings from previous similar reviews in
this area, including the introduction of profound work-
ﬂow changes (such as staff communication patterns or
dependence on technology) and new safety hazards
(such as system workarounds or alert fatigue),32 as well
as implementation barriers (such as poor access to com-
puters or unsupportive management teams) and facilita-
tors (such as teamwork and user involvement or
adequate staff training).33
In addition, the analysis of existing qualitative evi-
dence on the implementation and regular use of
ePrescribing in hospital settings from the perspective of
those involved in and/or affected by such technologies
could shed new light on the issue of addressing complex
data about healthcare quality and safety that cannot be
straightforwardly classiﬁed, quantiﬁed or elicited from
sources such as audit data, routine metrics and statistics
or incident-reporting systems.23 26 47
Finally, the ﬁndings of this review will inform an
ongoing longitudinal study exploring the effects of
implementing an ePrescribing system on care provision
and hospital work in paediatric hospital ward settings.48
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